Cancer registries in Japan: National Clinical Database and site-specific cancer registries
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605490333 | ||
| 003 | CHVBK | ||
| 005 | 20210128100504.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150201xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10147-014-0757-4 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10147-014-0757-4 | ||
| 245 | 0 | 0 | |a Cancer registries in Japan: National Clinical Database and site-specific cancer registries |h [Elektronische Daten] |c [Takayuki Anazawa, Hiroaki Miyata, Mitsukazu Gotoh] |
| 520 | 3 | |a Abstract : The cancer registry is an essential part of any rational program of evidence-based cancer control. The cancer control program is required to strategize in a systematic and impartial manner and efficiently utilize limited resources. In Japan, the National Clinical Database (NCD) was launched in 2010. It is a nationwide prospective registry linked to various types of board certification systems regarding surgery. The NCD is a nationally validated database using web-based data collection software; it is risk adjusted and outcome based to improve the quality of surgical care. The NCD generalizes site-specific cancer registries by taking advantage of their excellent organizing ability. Some site-specific cancer registries, including pancreatic, breast, and liver cancer registries have already been combined with the NCD. Cooperation between the NCD and site-specific cancer registries can establish a valuable platform to develop a cancer care plan in Japan. Furthermore, the prognosis information of cancer patients arranged using population-based and hospital-based cancer registries can help in efficient data accumulation on the NCD. International collaboration between Japan and the USA has recently started and is expected to provide global benchmarking and to allow a valuable comparison of cancer treatment practices between countries using nationwide cancer registries in the future. Clinical research and evidence-based policy recommendation based on accurate data from the nationwide database may positively impact the public. | |
| 540 | |a Japan Society of Clinical Oncology, 2014 | ||
| 690 | 7 | |a Cancer registry |2 nationallicence | |
| 690 | 7 | |a Nationwide database |2 nationallicence | |
| 690 | 7 | |a Risk factor |2 nationallicence | |
| 690 | 7 | |a Risk model |2 nationallicence | |
| 700 | 1 | |a Anazawa |D Takayuki |u Department of Regenerative Surgery, Fukushima Medical University, 1 Hikarigaoka, 960-1295, Fukushima, Japan |4 aut | |
| 700 | 1 | |a Miyata |D Hiroaki |u Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan |4 aut | |
| 700 | 1 | |a Gotoh |D Mitsukazu |u Department of Regenerative Surgery, Fukushima Medical University, 1 Hikarigaoka, 960-1295, Fukushima, Japan |4 aut | |
| 773 | 0 | |t International Journal of Clinical Oncology |d Springer Japan |g 20/1(2015-02-01), 5-10 |x 1341-9625 |q 20:1<5 |1 2015 |2 20 |o 10147 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10147-014-0757-4 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a review-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10147-014-0757-4 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Anazawa |D Takayuki |u Department of Regenerative Surgery, Fukushima Medical University, 1 Hikarigaoka, 960-1295, Fukushima, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Miyata |D Hiroaki |u Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Gotoh |D Mitsukazu |u Department of Regenerative Surgery, Fukushima Medical University, 1 Hikarigaoka, 960-1295, Fukushima, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t International Journal of Clinical Oncology |d Springer Japan |g 20/1(2015-02-01), 5-10 |x 1341-9625 |q 20:1<5 |1 2015 |2 20 |o 10147 | ||